6 New Weight Loss Drugs That Could Dethrone Ozempic - gizmodo.com
Google News • 1/22/2026
Summary
Six new weight loss drugs are being discussed as potential competitors to Ozempic. These drugs may outperform Ozempic with significant results. Wegovy is now available in pill form. A Wisconsin weight loss physician has provided insights on the impact of a GLP-1 pill, and a doctor has answered questions regarding GLP-1 medications.
Advertisement
Lindy Score Breakdown (V4.2)
72d
Age
1
Sources
from cluster
1729
Hours Since Seen
Final Score0/100
CategoryAntiLindy
StatusArchived
Recency Multiplier0% (0.5^1729/48)
Hero EligibleNo
Score is 0 because recency decay (0.5^1729/48 = 0.000000) reduced it below 0.5
Score BreakdownRisk 50
Source Reputation: Low-trust source (6/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 72 days - proven survivor
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: Trump administration prepares 100% tariffs on some imported drugs
Stat News • 2 days ago
STAT+: Trump announces 100% tariffs on brand-name drugs, with plenty of carveouts
Stat News • 2 days ago
STAT+: How health care could gum up Trump’s reconciliation push
Stat News • 2 days ago
STAT+: ‘Takeover Tuesday’ saves biotech’s quarter
Stat News • 2 days ago
STAT+: Lilly’s obesity pill enters the oral GLP-1 game, Novo responds
Stat News • 2 days ago
Opinion: STAT+: Cardiology’s finally prioritizing prevention — but what will it look like?
Stat News • 2 days ago
Opinion: My patient would rather take a peptide than a statin. That reveals an uncomfortable truth in medicine
Stat News • 1 day ago
STAT+: Medicare Advantage plans win extra $18.6 billion as feds cut star ratings measures
Stat News • 1 day ago
Supreme Court conversion therapy decision could ripple through medicine
Stat News • 1 day ago
STAT+: Proposed ‘preclinical obesity’ diagnosis ignites global debate among experts
Stat News • 2 days ago
Anti-Lindy Similar stories
STAT+: Pharmalittle: We’re reading about a Merck acquisition, the rise of former Loxo execs at Lilly, and more
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about an FDA OK for a rare disease drug, a grilling of the PTO chief, and more
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about Trump pushing drug pricing policy, Chinese biotech licensing, and more
Stat News • 5 days ago
STAT+: FDA approves Denali Therapeutics drug for Hunter syndrome
Stat News • 1 week ago